Regulators approved it Sept. 10 for adults with moderate to advanced liver damage but no cirrhosis. MASH resolved in about two-thirds of trial patients.
Recap by typeshit. Full story at Sixth Tone.
A Weird Science riff frames her before and after, crediting GLP-1 medication for taking her from 233 pounds down to 133.
The Post digs into how weight loss on GLP-1 drugs may be affecting marriages, and finds the answer is not simple.
She explains that GLP-1 drugs copy a hormone the body already makes, and says they can curb appetite, slow digestion and help with blood sugar.
She landed the Daily Mail front page this week discussing Ozempic face and the steps she says she took to protect her own.
GLP-1 researcher Daniel Drucker links to findings on Lilly's experimental retatrutide and sleep apnea. Details are at the link.
Goodman got sober in 2007 and says the craving shifted to food. Gupta argues a 2025 trial supports the idea, a link to GLP-1 craving research.
Loading…